1. Home
  2. VALN vs CYD Comparison

VALN vs CYD Comparison

Compare VALN & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • CYD
  • Stock Information
  • Founded
  • VALN 2012
  • CYD 1951
  • Country
  • VALN France
  • CYD Singapore
  • Employees
  • VALN N/A
  • CYD N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • CYD Industrial Machinery/Components
  • Sector
  • VALN Health Care
  • CYD Industrials
  • Exchange
  • VALN Nasdaq
  • CYD Nasdaq
  • Market Cap
  • VALN 488.9M
  • CYD 493.2M
  • IPO Year
  • VALN 2021
  • CYD 1994
  • Fundamental
  • Price
  • VALN $4.66
  • CYD $9.05
  • Analyst Decision
  • VALN Strong Buy
  • CYD
  • Analyst Count
  • VALN 2
  • CYD 0
  • Target Price
  • VALN $18.50
  • CYD N/A
  • AVG Volume (30 Days)
  • VALN 22.7K
  • CYD 18.1K
  • Earning Date
  • VALN 11-07-2024
  • CYD 08-12-2024
  • Dividend Yield
  • VALN N/A
  • CYD 4.20%
  • EPS Growth
  • VALN N/A
  • CYD 14.53
  • EPS
  • VALN N/A
  • CYD 1.17
  • Revenue
  • VALN $176,817,979.00
  • CYD $2,639,608,357.00
  • Revenue This Year
  • VALN $24.30
  • CYD $11.68
  • Revenue Next Year
  • VALN $16.05
  • CYD $4.06
  • P/E Ratio
  • VALN N/A
  • CYD $7.73
  • Revenue Growth
  • VALN N/A
  • CYD 15.32
  • 52 Week Low
  • VALN $4.60
  • CYD $7.85
  • 52 Week High
  • VALN $12.85
  • CYD $13.05
  • Technical
  • Relative Strength Index (RSI)
  • VALN 26.32
  • CYD 12.61
  • Support Level
  • VALN $4.63
  • CYD $9.05
  • Resistance Level
  • VALN $5.28
  • CYD $11.80
  • Average True Range (ATR)
  • VALN 0.18
  • CYD 0.42
  • MACD
  • VALN -0.09
  • CYD -0.26
  • Stochastic Oscillator
  • VALN 4.05
  • CYD 0.95

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: